Interleukin 6 (IL6) signaling is an intriguing target to study in neurodegenerative diseases, where non-canonical IL6 trans-signaling is thought to be the dominant pathological mechanism in the CNS [1]. This evidence concerns the gene IL6 and neurodegenerative disease.